NCT06608511
Liquid Biomarker Study in Melanoma and Non-Melanoma Skin Cancers No drug interventions Not Available Not Available not_yet_recruiting NCT06585410
Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma treatment 3 not_yet_recruiting NCT05620134
Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic Cancer treatment 1 / 2 recruiting NCT06384053
Skin Cancer and Hyperthermia and Radiotherapy No drug interventions treatment Not Available not_yet_recruiting NCT05845632
Time to Treatment and Disease-free Survival of Patients With High-risk Head-neck Cutaneous Squamous Cell Carcinoma No drug interventions Not Available Not Available active_not_recruiting NCT04362722
Intratumoral Administration of Daromun in Non-melanoma Skin Cancer Patients treatment 2 recruiting NCT04616248
In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors treatment 1 recruiting NCT06036836
Study of Favezelimab Coformulated With Pembrolizumab (MK-4280A) in Participants With Selected Solid Tumors (MK-4280A-010) treatment 2 recruiting NCT05108090
Sentinel Lymph Node Biopsy for Cutaneous Squamous Cell Carcinoma of the Head and Neck No drug interventions screening Not Available recruiting NCT04329221
Immunotherapy Before Transplantation for Skin Cancer Prevention in Organ Transplant Recipients prevention 2 not_yet_recruiting NCT04853602
IFx-Hu2.0 Expanded Access Program Not Available Not Available available NCT04916002
A Trial To Find Out If Vidutolimod Together With Cemiplimab Is Safe And If It Works In Adult Participants With Advanced Cancer Or Metastatic Cancer treatment 2 active_not_recruiting NCT04642287
Immunotherapy After Transplantation for Skin Cancer Prevention in Organ Transplant Recipients treatment 2 not_yet_recruiting NCT04632433
Neoadjuvant Plus Adjuvant Treatment With Cemiplimab in Cutaneaous Squamous Cell Carcinoma treatment 2 active_not_recruiting NCT02672254
New Strategies Against Cutaneous Squamous Cell Carcinoma No drug interventions Not Available Not Available completed NCT06008977
Exercise to Boost Response to Checkpoint Blockade Immunotherapy No drug interventions other Not Available recruiting NCT04710498
Neoadjuvant Atezolizumab in Surgically Resectable Advanced Cutaneous Squamous Cell Carcinoma treatment 2 active_not_recruiting NCT03836105
CemiplimAb Survivorship Epidemiology Not Available Not Available active_not_recruiting NCT06014697
OCT and Invasion in Cutaneous Skin Lesions No drug interventions Not Available Not Available active_not_recruiting NCT04502888
Ph1 Study of SL-172154 Administered Intratumorally in Subjects With Squamous Cell Carcinoma of the Head and Neck or Skin No drug interventions treatment 1 terminated NCT05878288
Deep sequencIng in Cutaneous Squamous CEll caRciNomas other 2 active_not_recruiting NCT04975152
Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell Carcinoma treatment 1 recruiting NCT04620200
Neo-adjuvant Nivolumab or Nivolumab With Ipilimumab in Advanced Cutaneous Squamous Cell Carcinoma Prior to Surgery treatment 2 recruiting NCT05724875
FLASH Radiotherapy for Skin Cancer No drug interventions treatment Not Available recruiting NCT04050436
Study Evaluating Cemiplimab Alone and Combined With RP1 in Treating Advanced Squamous Skin Cancer treatment 2 active_not_recruiting NCT06014619
Complications and Recurrences After Mohs Micrographic Surgery and Slow Mohs No drug interventions Not Available Not Available recruiting NCT05729139
Cemiplimab/Peg-Interferon-α in Advanced CSCC treatment 1 withdrawn NCT05695222
Cutaneous Squamous Cell Carcinoma Staging Study No drug interventions Not Available Not Available active_not_recruiting NCT03775525
Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or in Combination With Capecitabine in Metastatic Hormone Receptor Positive Breast Cancer treatment 1 active_not_recruiting NCT06046625
Needs and Preferences of Patients With Head-neck Cutaneous SCC No drug interventions Not Available Not Available active_not_recruiting NCT06536257
Personalised Immunotherapy Platform No drug interventions Not Available Not Available recruiting NCT06090266
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents treatment 1 / 2 recruiting NCT04160065
Immunotherapy With IFx-Hu2.0 Vaccine for Advanced Non-melanoma Skin Cancers treatment 1 active_not_recruiting NCT06384820
Study of Cemiplimab Alone or in Combination With Fianlimab and/or Other Experimental Agents in Adult Participants With Peri-operative Stage III/IV Cutaneous Squamous Cell Carcinoma (CSCC) treatment 2 withdrawn NCT04664582
Sentinel Lymph Node Biopsy for Cutaneous Squamous Cell Carcinoma of the Head and Neck No drug interventions treatment Not Available unknown_status NCT03901573
High-Risk Skin Cancers With Atezolizumab Plus NT-I7 treatment 1 / 2 terminated NCT05076760
MEM-288 Oncolytic Virus Alone and in Combination With Nivolumab in Solid Tumors Including Non-Small Cell Lung Cancer treatment 1 recruiting NCT05086692
A Beta-only IL-2 ImmunoTherapY Study treatment 1 / 2 recruiting NCT05888844
A Study to Evaluate INCB099280 in Participants With Advanced Cutaneous Squamous Cell Carcinoma No drug interventions treatment 2 active_not_recruiting NCT06536946
B-catenin in Cutaneous Squamous Cell Carcinoma and Its Mimickers No drug interventions Not Available Not Available recruiting NCT03889912
Intralesional Cemiplimab for Adult Patients With Cutaneous Squamous Cell Carcinoma or Basal Cell Carcinoma treatment 1 recruiting NCT04389112
Study of Metabolic Changes in the Transformation Malignant Precancerous Skin Lesions No drug interventions diagnostic Not Available recruiting NCT06020612
Interobserver Variability Desmoplasia No drug interventions Not Available Not Available active_not_recruiting NCT05256381
A Study of SOT101 in Combination With Pembrolizumab to Evaluate the Efficacy and Safety in Patients With Selected Advanced Solid Tumors treatment 2 active_not_recruiting NCT06567314
Phase 2 Study of Ivonescimab in Patients With Cutaneous Squamous Cell Carcinoma treatment 2 not_yet_recruiting NCT02076243
Treatment With Nab-paclitaxel in Cutaneous SCC treatment 2 terminated NCT04596033
TiTAN-1: Safety, Proliferation and Persistence of GEN-011 Autologous Cell Therapy treatment 1 terminated NCT01500954
Microarray Analysis of microRNA Expression Profiles in Cutaneous Squamous Cell Carcinoma No drug interventions Not Available Not Available completed NCT05377905
Microneedle Array Plus Doxorubicin in Cutaneous Squamous Cell Cancer (cSCC) treatment 1 / 2 recruiting NCT06342297
Dermatoscopy Guided Resection for Skin Cancer No drug interventions treatment Not Available recruiting NCT06577311
Evaluating the Use of Photodynamic Therapy to Treat Facial Cutaneous Squamous Cell Carcinoma in Situ (SCCis) treatment 2 recruiting NCT04301011
Study of TBio-6517 Given Alone or in Combination With Pembrolizumab in Solid Tumors treatment 1 / 2 terminated NCT04429542
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT04242199
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT04349436
A Phase 1B/2 Study of RP1 in Solid Organ Transplant Patients With Advanced Cutaneous Malignancies No drug interventions treatment 1 / 2 recruiting NCT04925713
IFx-Hu2.0 for the Treatment of Patients With Skin Cancer treatment 1 completed NCT05565417
Study of the Monoclonal Antibody IMT-009 in Patients With Advanced Solid Tumors or Lymphomas treatment 1 / 2 recruiting NCT03082534
Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma treatment 2 active_not_recruiting NCT04272034
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT04616196
Study of NKTR 255 in Combination With Cetuximab in Solid Tumors treatment 1 / 2 completed NCT05238363
The Efficacy and Safety of HLX07 in Locally Advanced or Metastatic Cutaneous Squamous Cell Carcinoma (CSCC) No drug interventions treatment 2 unknown_status NCT04985825
Imgatuzumab in Patients With Advanced Cutaneous Squamous Cell Carcinoma treatment 2 withdrawn NCT05220748
RM-1995 Photoimmunotherapy, as Monotherapy or Combined With Pembrolizumab, in Patients With Advanced CuSCC and HNSCC treatment 1 withdrawn NCT05493826
Real World Study on the Use of Cemiplimab in Adult Patients in UK No drug interventions Not Available Not Available completed NCT03524326
Testing Lenvatinib and Cetuximab in Patients With Advanced Head and Neck Squamous Cell Carcinoma and Cutaneous Squamous Cell Carcinoma treatment 1 completed NCT05859074
A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer treatment 1 active_not_recruiting NCT05741073
Outcome Research of a European Registry Platform on Real-world Treatment Data of Patients With Advanced NMSC No drug interventions Not Available Not Available recruiting NCT04242173
Cemiplimab-rwlc for Unresectable Locally Recurrent and/or Metastatic CSCC treatment 2 terminated NCT05286294
Microbiota Transplant to Cancer Patients Who Have Failed Immunotherapy Using Faeces From Clinical Responders treatment 2 recruiting NCT06288191
Neoadjuvant Nivolumab and Relatlimab in Cutaneous Squamous Cell Carcinoma treatment 2 not_yet_recruiting NCT04339062
Cemiplimab in AlloSCT/SOT Recipients With CSCC treatment 1 / 2 active_not_recruiting NCT05482880
Decisional Conflicts, Health-related QoL and Satisfaction With Care in High-risk cSCC in the Head-neck Region No drug interventions Not Available Not Available recruiting NCT03492489
Expanded Access Protocol for Cemiplimab in Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma Not Available Not Available no_longer_available NCT05574101
A Study of Radiation Therapy and Cemiplimab for People With Skin Cancer treatment 2 recruiting NCT03212404
Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers treatment 1 recruiting NCT03969004
Study of Adjuvant Cemiplimab Versus Placebo After Surgery and Radiation Therapy in Patients With High Risk Cutaneous Squamous Cell Carcinoma treatment 3 recruiting NCT04252612
Biological Outcomes of Pramlintide in Resectable Cutaneous Squamous Cell Carcinoma: A Pilot Study treatment 0 withdrawn NCT03982212
A Window of Opportunity Trial of Intratumoral Injection of Copaxone® in Patients With Percutaneously Accessible Tumors treatment 1 active_not_recruiting NCT05358938
Exercise to Boost Response to Checkpoint Blockade Immunotherapy treatment 0 active_not_recruiting NCT04154943
Study of Cemiplimab in Patients With Type of Skin Cancer Stage II to IV Cutaneous Squamous Cell Carcinoma treatment 2 active_not_recruiting NCT02218164
Capecitabine or 5-FU With Pegylated Interferon Alpha-2b in Unresectable/Metastatic Cutaneous Squamous Cell Carcinoma treatment 2 completed NCT04913220
A Study of SAR444245 Combined With Cemiplimab for the Treatment of Participants With Various Advanced Skin Cancers (Pegathor Skin 201) treatment 1 / 2 active_not_recruiting NCT02321982
Same-day Versus Separate-day Preoperative Consultation for Mohs Surgery No drug interventions health_services_research Not Available withdrawn NCT06610071
NIFR Image-guided Surgery for Malignant Soft Tissue Tumor With Low-dose SWIG Technique No drug interventions treatment 1 not_yet_recruiting NCT03353077
Alpha Radiation Emitters Device for the Treatment of Squamous Cell Carcinoma (DaRT) No drug interventions treatment Not Available completed NCT03822988
ACCEPTABILITY AND WRITING FREQUENCY OF ADVANCED DIRECTIVES IN ONCO-DERMATOLOGY PATIENTS No drug interventions Not Available Not Available unknown_status NCT02964559
Pembrolizumab in Patients With Locally Advanced or Metastatic Skin Cancer treatment 2 completed NCT00954226
Phase Ib Study of Erlotinib Prior to Surgery in Patients With Head and Neck Cancer treatment 1 active_not_recruiting NCT05269381
Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors treatment 1 / 2 recruiting NCT06223659
EMLA Topical Cream for Treatment of Pain in Patients Receiving Intra-Dermal Technetium 99 Injections for Lymphoscintigraphy for Skin Cancers treatment 2 recruiting NCT04234113
Study of SO-C101 and SO-C101 in Combination With Pembro in Adult Patients With Advanced/Metastatic Solid Tumors treatment 1 active_not_recruiting NCT03944941
Avelumab With or Without Cetuximab in Treating Patients With Advanced Skin Squamous Cell Cancer treatment 2 active_not_recruiting NCT02978625
Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers treatment 2 active_not_recruiting NCT03108131
Cobimetinib and Atezolizumab in Treating Participants With Advanced or Refractory Rare Tumors treatment 2 completed NCT01807546
Oral Rigosertib for Squamous Cell Carcinoma treatment 2 completed NCT03546998
Epidermoid Cancer Development in Esophageal Achalasia No drug interventions Not Available Not Available recruiting NCT01581840
Radiochemotherapy With Panitumumab in the Localised Epidermoid Carcinoma of the Anus treatment 1 / 2 completed NCT04583605
The Aim of This Study is to Demonstrat That Vacuum-assisted Closure Versus Conventional Wound Closure Enables to Diminish Local Complications After Lymph Node Dissection in Patients With Metastatic Skin Tumors No drug interventions Not Available Not Available unknown_status NCT03773744
MG1-MAGEA3 With Ad-MAGEA3 and Pembrolizumab in Patients With Previously Treated Metastatic Melanoma or Cutaneous Squamous Cell Carcinoma treatment 1 withdrawn NCT01764607
Sirolimus in Kidney Transplant Patients With Squamous Cell Skin Carcinoma treatment 2 terminated NCT02997553
Fluorescence for Sentinel Lymph Node Identification in Cancer Surgery diagnostic 3 completed NCT01017185
Study of HF10 in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions No drug interventions treatment 1 completed NCT00563290
Dasatinib in Treating Patients With Unresectable or Metastatic Squamous Cell Skin Cancer or RAI Stage 0-I Chronic Lymphocytic Leukemia treatment 2 completed NCT01823679
Capecitabine in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Skin treatment 2 terminated NCT04480645
CivaDerm(TM) Surface Therapy Pilot Study No drug interventions treatment 0 unknown_status NCT03370861
How Microbes and Metabolism May Predict Skin Cancer Immunotherapy Outcomes No drug interventions Not Available Not Available terminated NCT05246228
Immune System Modulation and Outcome in High-risk cSCC Treated With Surgery and Radiotherapy No drug interventions Not Available Not Available not_yet_recruiting NCT06327971
Enhanced Outcome Prediction in Cutaneous Squamous Cell Carcinoma Using Deep-learning and Computational Histopathology No drug interventions Not Available Not Available active_not_recruiting NCT01465815
Phase I/II Study of Postoperative Adjuvant Chemoradiation for Advanced-Stage Cutaneous Squamous Cell Carcinoma of the Head and Neck (cSCCHN) treatment 1 / 2 withdrawn NCT04204837
Nivolumab for Treatment of Squamous Cell Carcinoma of the Skin treatment 2 recruiting NCT02347813
Preventing Squamous Cell Skin Cancer prevention 2 completed NCT06014086
Intratumoral PH-762 for Cutaneous Carcinoma No drug interventions treatment 1 recruiting NCT00089180
T4N5 Liposomal Lotion in Preventing The Recurrence of Nonmelanoma Skin Cancer in Patients Who Have Undergone a Kidney Transplant prevention 2 completed NCT03737721
The UNSCARRed Study: UNresctable Squamous Cell Carcinoma Treated With Avelumab and Radical Radiotherapy treatment 2 active_not_recruiting NCT03291002
Study of Intratumoral CV8102 in cMEL, cSCC, hnSCC, and ACC treatment 1 unknown_status NCT05490485
Camrelizumab Combined With Cisplatin in the Treatment of Advanced Cutaneous Squamous Cell Carcinoma treatment 2 recruiting NCT04892849
Clinical Benefit and Biomarker Analysis of Combination of PD-1/PD-L1 Immune Checkpoint Inhibitors and Radiotherapy No drug interventions Not Available Not Available recruiting NCT02717936
Investigation of Desmoplastic Squamous Cell Carcinoma No drug interventions diagnostic Not Available unknown_status NCT03894618
SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or Lymphomas No drug interventions treatment 1 completed NCT02507076
Isolated Limb Perfusion With Melphalan in Treating Patients With Stage IIIB-IV Melanoma or Sarcoma treatment Not Available withdrawn NCT03621462
Elucid Labs AIDA™ - Labelled Image Acquisition Protocol No drug interventions diagnostic Not Available unknown_status NCT01984892
Treatment of Solid Tumors With Intratumoral Hiltonol® (Poly-ICLC) treatment 2 terminated NCT05886140
Carrilizumab Combined With White Purple for Squamous Cell Carcinoma of Skin treatment Not Available recruiting NCT00126555
Gefitinib in Treating Patients Who Are Undergoing Surgery and/or Radiation Therapy for Locally Advanced or Recurrent Squamous Cell Skin Cancer treatment 2 completed NCT02324608
Cetuximab Before Surgery in Treating Patients With Aggressive Locally Advanced Skin Cancer treatment Not Available completed